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A meeting on the health dfect ofarsenic (As), its modes ofaction, and areas in need offuture
research was held in Hunt Valley, Maryland, on 22-24 September 1997. Exposure to As in
drinking water has been associated with the devdopment ofskin and interal cancers and non-
carcinogenic effects such asdiabetes, peripheral neuropathy, andcardiovaculardiseases. There is
little dataon specific mechanism(s) ofaction forAs, butagreatdeal ofinformation on possible
modes ofaction. Although arsenite [As(III)] can inhibit morethan 200enzymes, events underly-
ing the induction ofthe noncarcinogenic effects ofAs are not understood. With respect to car-
cinogenic4ty,As can affec DNArepair, methylation ofDNA, and increase radical formation and
activation ofthe protooncogene c-myn, but none of these potential wys have widespread
acceptance as the principal etiologic event In addition, there are no accepted modes for the
study ofAs-induced ogenesit At the final meeting session we considered research needs.
Among the most important areas cited were a) As metabolism and its interaction with celiular
constituents; 6) possiblebioaccmulation ofAs; c) interactions with othermetals; 4) effiects ofAs
ongenetic material; e) development ofanimal models andceil systems tostudyeffects ofAs; and
Jp a better rerizaion ofhuman exposures as related tohealthrisks. Some ofthebarriers to
the advmcement ofAs research induded an apparentla"c ofinterest in the United States on As
research; lackofrelevant animal models; difficultywith adoption ofuniform methodologes; lack
ofaccepted biomarkers; and the need for acentral storage repositoryfor stored s ens. ey
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Arsenic (As) is anaturallyoccurringelement, is
present in food, soil, air, and water, and all
human populations are exposed to it in one
form or another. The major sources of expo-
sure for the majorityoftheU.S. population are
from food and water. Food contains both
organic and inorganic As, whereas drinking
water contains primarily inorganic forms ofAs.
For most people exposure from air and soil is
minimal, but in certain instances, soil may be
an important route forexposure in children. In
addition, there are industrial exposures for
workers. For example, semiconductor workers
are exposed to gallium arsenide and some
farmers handle arsenical herbicides. A variety
ofadverse health effects, e.g., skin and internal
cancers, cardiovascular, and neurological
effects, have been attributed to As exposure,
primarily from drinking water. Ofthe various
arsenical compounds, current evidence indi-
cates that based on acute lethality data, the
inorganic arsenicals are moreacutely toxic than
most organic forms. There are suggestions that
the chronic toxicity ofmany organic forms of
As, especially those found in fish and shellfish,
is also less than the inorganic As; the available
information, however, is ftrom indirect sources.
For example, an organic arsenical from fish,
arsenobetaine, is absorbed and excreted as the
parent chemical and appears to exert little
acute toxicity. However, no chronic bioassays
in animals or surveys in humans have been
conducted. Conversely, the inorganic com-
pounds are acutely toxic and long-term expo-
sure in humans has been associated with vari-
ous cancers. There is no generally accepted
animal modelforAs-induced cancer.
On 22-24 September 1997, the scien-
tific meeting "Arsenic: Health Effects,
Mechanisms ofAction and Research Issues"
was held at Marriott's Hunt Valley Inn in
Hunt Valley, Maryland. The meeting was
cosponsored bytheNational Cancer Institute,
the National Institute of Environmental
Health Sciences, and the U.S. Environmental
Protection Agency (EPA). Impetus for this
meeting was provided by the upcoming 1
January 2000 EPA As rule promulgation and
the recentworldwide reports ofadverse effects
resulting from exposure to As in drinking
water. The purposes of this meeting were to
gather scientists conducting research on As or
in related areas, listen to their research presen-
tations, discuss problems, and recommend
research areas. The meeting was divided into
six lecture-discussion sessions: Chemistry,
Toxicology and Exposure, Metabolism,
Epidemiology, Biodynamics, Molecular
Mechanisms of Carcinogenesis, and Dose-
Response Considerations. A seventh session
(Summary Discussion) was convened to rec-
ommend research areas, discuss barriers to




The integral relationships between arsenical
exposure, in vivomethylation ofAs, and mech-
anisms ofinorganic/methylated arsenical toxic-
ity are central to providing appropriate risk
assessment calculations for human populations
exposed to this element. Exposure ofhuman
populations to elevated concentrations ofinor-
ganic As in drinking water from wells in
Taiwan, Inner Mongolia, and China has
resulted in usual dermatological manifestations
that induded raindrop pigmentation, hyperk-
eratoses, and skin cancer (1,2). In addition,
subsequent analyses indicated the presence of
the characteristic As-induced uroporphyrin-
uria, coproporphyrinuria, and a tubular pro-
teinuria. The probable mechanisms of in vivo
As methylation involve a 2-electron reduction
of arsenate [As(V)] to arsenite [As(III)] and a
methyl transfer reaction involving 5-adenosyl-
methioine (SAM) to generate the methylarson-
ic acid (MMA) and dimethylarsinic acid
(DMA) metabolites (3,4). The inhibitory
action ofvarious arsenicals and arsenothiols on
glutathione reductase were discussed in rela-
tion to theprooxidanteffects ofarsenicals. The
variety of inhibitory effects of arsenicals on
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nicotine adenine dinucleotide-linked sub-
strates-e.g., support of mitochondrial respi-
ration, decrease in adenosine triphosphate
(ATP) synthesis, and increased phosphoryla-
tion of other intracellular biochemical
species-were discussed in relation to the gen-
eration of reactive oxygen species (ROS),
oxidative stress, and altered cellular gene regu-
lation (5). In particular, the roles ofoxidative
insult in inducing the stress protein response,
including members of the heat shock protein
70 family and the 32-kD stress protein (heme
oxygenase), which may be involved in reduc-
ing the potential of intracellular heme and
porphyrins to participate in the formation of
ROS. Other stress proteins such as those in
the 27, 60, and 90 kD families are also
induced by As, indicating a broad proteotoxic
effect following cellular exposure to this ele-
ment (6,7). The relationship(s) between
arsenical-induced cell injury/cell death and the
carcinogenic response require further study.
Metabolism
Reports were presented on the diversity ofthe
methods that mammals use to detoxify inor-
ganic As. Although many organisms can
methylate inorganic As, some mammals,
including the marmoset monkey, chimpanzee,
guinea pig, and many South American mon-
keys lack or are deficient in liver arsenite
methyltransferases (3). At present, this is the
best experimental evidence for polymorphism
of these methyltransferase genes. A major
question raised by these studies is whether
methylation is the primary detoxification
pathway of inorganic As(III). Diversity was
also shown in how different tissues vary in
arsenite methyltransferase activity. For the
mouse, the greatest activity is in mouse testis,
which is greater than kidney > lung > liver
(3,8). These data show that the liver is not the
only site of inorganic As(III) methylation, as
has been claimed in the past. When the
chelating agent DIMAVAL (2,3-dimercapto-
1-propanesulfonic acid) was given to 24 sub-
jects in Chile, there was a marked change in
MMA and DMA excretion in the urine. The
MMA excretion before DIMAVAL was 14%;
after oral administration, MMA increased to
42% oftotal As excretion (9.
Variations in As metabolism in humans
were also discussed because all groups of
humans studied methylate inorganic As (10).
Future research on factors affecting As methy-
lation is needed. However, the patterns ofAs
metabolites in urine have substantial interindi-
vidual variation. For example, a small number
ofwomen in the Argentina Andes excrete little
MMA in their urine (11). Factors that appear
to influence the methylation of inorganic As
are the species ofAs that the individuals are
exposed to, dose levels, routes ofexposure, and
type of diet. Arsenic metabolism in bacteria
was discussed and some bacteria were resistant
to As. For example, the resistance of
Escherichia coli to inorganic As was due to the
products of five genes. The genes and their
products are ArsR-metal binding protein with
a domain for As(III) and Sb(III); ArsD-metal
binding protein with three pairs ofvicinal cys-
teine residues; ArsA, a catalytic unit of arsen-
ite-translocatingATPase; ArsB membrane sec-
tor ofArsA gene product and ArsC, an arsen-
ate reductase-the product is arsenite, which
is the substrate of the pump. Such studies
need to be extended to mammalian systems.
Because methylation is important in As
metabolism, methylation reactions, which
involve interactions, inhibitors, and seleni-
um-As interactions, were also discussed. This
is of particular importance because of the
antagonism between As and selenium in many
biologic systems. In addition, many investiga-
tors do not realize the various pathways avail-
able for mammals to methylate a substrate and
the complex interactions and relationships of
these pathways.
In South America, variations of human
responses to As exposure have been reported
(11). This area ofvariation in response to As is
rapidly expanding and may need newer
approaches and different methods ofanalysis.
One potential tool involves usingpharmacoki-
netic (PK) models based on ingestion of
As(III), As(V), MMA, DMA, or any mixture
of these four compounds in the human (12).
Such models describe tissue burdens of As
species as a function oftime and dose. The PK
model is being used as the framework to test a
receptor-mediated mechanism of action for
inorganic As. In addition, the potential impor-
tance ofpolymorphism in As toxicology was
examined. Basic biochemical and molecular
biology studies on the mechanisms of As
metabolism are scarce.
Epidemiology
Two studies of As exposure and cancer in
Chile were presented. The first, an ecological
cohort study, used community estimates ofAs
in water and age-specific ingestion rates (13).
This study found an association between As in
drinking water at 50 ig/L and skin cancer and
four internal cancers. The second study, a
case-control study, found an association
between bladder cancer and As exposure, as
reflected in statistically significant changes in
odds ratios with an estimated lifetime cumula-
tive exposure to As (13).
Studies involving cancer and noncancer
end points after As exposure in Taiwan in
the Blackfoot disease endemic areas were
described (14). The study types included eco-
logical correlation, case-control, and cohort
studies. Key findings included an association
between As and multiple health effects in
particular, diabetes and hypertension-as well
as several cancers. Skin lesions were the most
sensitive sign of As exposure. Several factors,
such as inadequate nutrition and genetics,
appeared to enhance susceptibility to As-
induced disease(15,16).
Analyses of differences in skin cancer cell
types as a function of a racial group and As
exposure were presented. These analyses
showed that among Euro-Americans, basal
cell carcinoma was the most frequent type of
both As-induced skin cancer and skin cancers
from other causes. Among Asians, Bowen dis-
ease was the mostfrequent type ofAs-induced
skin cancer, but not in skin cancers from other
causes. These studies suggest an interaction
between skin melanin content, ultraviolet
(UV)light, andAs-induced skin cancer.
In India, individuals exposed to elevated
inorganic As levels indrinking water showed a
range of health effects including peripheral
vascular disease, noncirrhotic portal fibrosis,
lung symptoms, and polyneuropathy. Arsenic
in Taiwan, skin pigmentation changes and
hyperkeratoses were the most sensitive indica-
tors ofinorganic As exposure (17).
A recentstudy in Thailand found thatskin
manifestations, including skin cancer, were
associated with elevated levels of inorganic As
in drinking water; females were more affected
than males. Tests ofmental function also indi-
cated an association between As and several
indicators offunction, such asintelligence quo-
tient tests. Several factors, such as employment
status and type, appeared to affect susceptibili-
ty toinorganic Astoxicity (18).
A case-control study of skin cancer,
specifically basal cell carcinomas, in Hungary
found an increased risk of a basal cell carcino-
ma associated with elevated levels of atmos-
pheric As from coal combustion. This was
particularly apparent in cases diagnosed before
1982 as compared to cases diagnosed after
1986. It is important to note that air concen-
trations ofAs began to decline in 1971. In
addition, the same investigators reported that
basal cell carcinomas were associated with ele-
vatedoccupational exposure to airborne As.
In the United States, preliminary results
based on community estimates of exposure
from a Utah cohort mortality study were pre-
sented (19). These results indicated an associa-
tion between inorganic As exposure and cer-
tain cancers as well as noncancer effects,
including hypertension and diabetes. A study
design for an analysis of As metabolism in
U.S. populations was presented. Finally,
efforts to identify U.S. communities with ele-
vated levels of As in drinking water were
described (19).
Arsenic Biodynamics
This session addressed the potential benefi-
cial effects of As. Whether it is nutritionally
essential for human health is heing debated.
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Arsenic is a growth factor for animal nutri-
tion, particularly chickens, although data
demonstrating potential beneficial effects for
humans are lacking (20). The definition of
nutritionally essential trace elements (ETEs)
has evolved over the past 50 years and may
be expected to expand as the result offuture
research. The criteria for essentiality for
human health are that withdrawal or absence
of the ETE from the diet produces either
functional or structural abnormalities and
that the abnormalities are related to or a con-
sequence ofspecific biochemical changes that
can be reversed by the presence ofthe ETE.
In this regard, As essentiality has not been
convincingly demonstrated. However, the
influence ofAs on human health may not be
easily definable. Recent studies show that
anomalies or imbalances in trace metals can
influence human health and well-being with-
out necessarily producing overt effects. In
addition, it is now recognized that clinical
expression of a latent deficiency or excess is
often contingent on variables such as changes
in general malnutrition or challenges such as
stress, infection, or injury. Some signs ofAs
deprivation in animals include perinatal mor-
tality, enlarged spleens, osmotic fragility of
erythrocytes, and rough hair coats. In addi-
tion, a low intake ofinorganic As reportedly
reduces SAM levels, alters production of
polyamines, and affects methylation path-
ways. It was hypothesized that inorganic As
played a role in methionine metabolism.
Arsenic reportedly protects against selenium
toxicity; one study suggested a mechanism




Arsenic does not directly react with DNA or
cause gene mutations, except to a small
extent at high doses. However, it does cause
gene amplification and chromosomal damage
at lower doses and can enhance mutagenesis
by other agents, apparently by inhibiting
DNA repair. Because no DNArepair enzyme
is sensitive to inhibition by arsenite, it is like-
ly that arsenite can interfere with the control
of DNA repair rather than with the repair
enzymes (5). Arsenite can also cause aneu-
ploidy. Unlike spindle poisons, arsenite does
not inhibit spindle fiber formation; instead, it
deranges the spindle apparatus, possibly by
accelerating microtubule polymerization. In
work on a new cell transformation system
using rat liver epithelial cell line TRL 1215,
chronic exposure to arsenite-induced malig-
nant transformation was associated with glob-
al DNA hypomethylation, decreased DNA
methyltransferase activity, and activation
(overexpression) ofthe protooncogene c-myc.
These results suggest that arsenite mayact as a
carcinogen by causing DNA hypomethyla-
tion leading to aberrant gene expression (23).
Opposite results on DNA methylation by
arsenite were seen on the p53 promoter in
human lung A549 carcinoma cells. Chronic
exposure to arsenite caused a progressive
increase in CpG methylation within the p53
promoter, which would be expected to block
transcription ofthe p53 gene (24). The p53
gene is an important tumor-suppressor gene
whose protein product plays an important
role in cell cycle control, apoptosis, and con-
trol ofDNA repair. Altered expression ofp53
and changes in cell cycle distribution were
reported in three cell lines 24 hr after treat-
ment with arsenite. Cells transfected with a
mutant p53 gene showed increased arsenite
sensitivity. Administration ofthe inorganicAs
metabolite, dimethylarsinic acid (DMA), in
large doses caused DNA damage to the
mouse lung. In cultured human alveolar L-
132 cells, DMA also caused induction of
DNA strand breaks, DNA-protein cross-
links and alcali-labile sites. It also acted as a
tumor promoter in mouse lung initiated with
4-nitroquinoline 1-oxide. The mechanism of
action is thought to be via a dimethyl arsine
radical formed in cells from DMA (25).
Dose Response Concentrations
Several hypotheses (e.g., gene amplification,
alteration ofmethylation patterns, and radical
formation) concerning the potential mecha-
nisms by which inorganic As could induce
cancer were presented. None ofthese possible
pathways have received widespread accep-
tance, probably for two reasons. First, mecha-
nistic studies of inorganic As have been the
subject offairly recent investigations, and sec-
ond, there are no universally accepted animal
models for the study ofAs-induced carcino-
genesis. Although not unanimous, there was a
lot ofsupport, based on known genetic effects
ofAs, for a nonlinear dose-response curve for
the carcinogenic effects ofAs (26). Comments
on the shape of the dose response elicited
comments on how to model such a response.
No condusionswerereached on this aspect.
Summary Discussion and
Recommendations
At the end of the workshop, questions and
recommendations were developed by the
attendees and the session chairs. Broadly
speaking, these included both basic and
human research initiatives that were felt to be
ofimportance in the goal ofmore fully assess-
ing the risk presented by As in the environ-
ment. Several important barriers to the
advancement ofresearch in As carcinogenicity
and toxicology were perceived, involving both
fundingand technical elements. These barriers
were discussed in the hopes ofproviding some
direction toward resolution ofthese issues.
Research needs assessment. Some of the
most important basic research needs thatwere
discussed included several aspects of As
metabolism and its interactions with living
cells. InorganicAs can often be methylated by
cells, which appears to reduce its acute toxic
effects in manycases. Although it is methylat-
ed in many tissues, this enzyme activity in
most tissues has not been well defined and
such tissue specificity in methylation may
have important implications in toxicity and
carcinogenesis. The metabolism of inorganic
As in various cell lines, induding human cell
lines, would be an important aspect of these
studies. Methylation ofAs appears to reduce
its acute toxic effects in many cases. With
respect to its chronic effects, there are some
data that the methylated forms (MMA and
DMA) can also be toxic: this deserves further
research. Some species showa minimal capac-
ity for methylation ofAs and it is an open
question how these nonmethylator animals
survive in the face ofAs exposure.
The question ofAs bioaccumulation was
considered an important area for additional
effort and the means by which the various As
species enter and leave cells were considered
an important element of this effort. These
studies should focus on mammalian cells and
include human cells. Arsenobetaine and
arsenocholine accumulate in various seafoods,
although knowledge of their effects in mam-
mals is scant. IfAs does in fact bioaccumulate,
what is the storage form? The interaction of
the inorganicAswith cellular proteins may be
the key. Many times cells can show native or
acquired resistance to metals and this resis-
tance, at times, involves protein binding. The
existence and mechanisms of resistance to As
need more in-depth exploration. Comparative
studies of nonhuman primate species that
vary in methylation capacity would be an
important step in answering some of these
questions. Abnormal methylation patterns
may also occur and may be based in genetic
variation or may be due to disease states.
Additionally, how intestinal microflora may
vary in its ability to process inorganic As in
human and animals may be important in
defining the actual form and extent ofexpo-
sure toAs.
Several issues were mentioned in the
Methods Development session. The develop-
mentofmethods to determineAs bioavailabil-
ity was considered important in defining risk
from environmental As. Separation ofsome of
the various forms ofAs is currently considered
problematic; method development would be
important. Development ofbiomarkers ofAs
exposureand toxicity is also adearneed.
Gender and age differences in susceptibili-
ty to As are poorly defined and such differ-
ences could explain the basis ofsensitivity in
certain subpopulations. Immunotoxicity,
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including immunosuppression, is often one of
the most subtle effects ofa toxic agent but has
not been well defined forAs.
Metal-metal interactions are important in
the toxicity of many metals. The role of
essential metals such as chromium, cobalt,
zinc, and selenium in As toxicity has not been
adequately explored. Nutrition studies should
define the interactions of As with essential
metals and proteins. Similarly, the effect of
other toxic inorganics, such as cadmium, lead,
and mercury on the toxic potential ofAs has
not been defined. In an environment where
multiple exposures are the rule rather than the
exception, such interactions may be critical in
defining toxic potential. Any synergistic and
additive toxic effects of arsenicals in cellular
systems should be defined. In addition, some
metals are redox active and will generate
ROS. There is some evidence that methylated
As compounds may cause peroxidative dam-
age to cellular components at high doses,
although this aspect ofAs toxicity needs to be
more fully explored. For instance, the chem-
istry of As radicals is poorly understood.
Questions remain concerning the formation
ofROS by As at low doses, a factor ofcritical
importance in defining mechanistic signifi-
cance. The development of noninvasive
methods to assay oxidative damage would
greatly facilitate such studies.
On the molecular level there is clear evi-
dence that As can induce aberrant gene
expressions. The effects ofAs on signal trans-
duction may be critical to the modification of
gene expression. Whether specific gene expres-
sions induced by As are transitory or perma-
nent could have important impact for toxic
mechanisms and should be explored.
Much ofthe discussion on research needs
focused on the carcinogenic potential of As.
The absence of clear animal models for this
important human carcinogen was considered
a major issue. Establishing animal models
should be encouraged because so many ofthe
mechanistic studies that need to be conducted
cannot be done in humans. The development
ofwhole-animal and cell culture systems for
defining the carcinogenic process for As was
considered critical to advancing our knowl-
edge in this area. Further mechanistic studies
defining the genotoxic effects (such as aneu-
ploidy, comutagenesis, and chromosome
aberrations) at the molecular level were pro-
posed. It is possible that different mechanisms
ofactions for As may apply at different stages
of carcinogenesis or in different target sites.
The genetic disruptions induced byAs during
transformation need further elucidation.
Defining the genetic changes in As-induced
tumors and in As-transformed cells would
assist in defining the molecular events in As
carcinogenesis. Rodent model systems need to
be relevant to human exposures to the extent
possible and consideration of diet and expo-
sure to other potential carcinogens (i.e., UV,
other metals) need to be assessed. The model
systems ofcell transformation also need to be
relevant with regard to humans in both the
use of reasonable dosages and cell types that
would be representative of target sites.
Defining the basis for the apparent differences
in susceptibility between human and rodents
for cancer would be a great step forward.
Model systems for various stages of carcino-
genesis may be important in this regard and
the existence of multiple mechanisms of car-
cinogenesis should not be excluded for As.
The investigation of how preneoplastic
lesions that develop in As exposures are asso-
ciated with tumors may also allow the use of
these as biomarkers.
Several research needs that involved
human study were discussed. Overall, a bet-
ter characterization ofhuman As exposure is
required to more precisely define actual
health risks. This should include defining
actual doses and durations ofexposure. Host
modifiers of the response to As, including
diet and genetic polymorphisms that may be
of etiological significance in development of
disease, should also be studied. There is evi-
dence that susceptibility to As toxicity is
higher in people who are nutritionally defi-
cient, although the specific nutritional defi-
ciencies need to be defined. The exploration
and validation of mechanistically based bio-
markers are a key element in defining adverse
effects of As exposure. An important ques-
tion about the reversibility ofthe effects ofAs
in humans remains. Locations that have sub-
stantially reduced As levels in their drinking
water should be evaluated to identify any
correlated reduction in adverse health effects.
Determination of the lowest concentrations
at which dermal signs of As toxicity are
observed in international studies would help
establish the lower dose limit in the United
States. All ofthese factors point to the need to
identify mechanistic components of some
dose-response models to provide valid risk
assessment. Arsenic always, ethical issues for
human studies need to be carefully considered.
Specific epidemiology studies were
recommended that considered the following
elements: characterization of dose-response
relationships; characterization of the dura-
tion-response relationships; linkage to mech-
anistic studies; and evaluation ofpopulation-
variability, especially as related to mecha-
nisms. The use of multicenter comparative
epidemiology studies could facilitate these
studies and these should have the following
attributes: a) consistent quality control mea-
sures; b) standardized questionnaires (e.g.,
describing host factors, etc.); c) different pop-
ulations with overlapping exposures; d)l a
well-characterized exposure, including As
species, bioavailability, etc., in all exposure
media (food, air, water); e) characterization of
individual exposure;f) use ofstandard refer-
ence materials; and g) consider the use of a
centralized analytical laboratory. To enhance
the comparability and validity ofsuch studies,
the effects of As must be well defined using
consistent criteria. This would include the
standardization of types of skin lesions and a
focus on known target sites (lung, skin, and
bladder for cancer). Investigation of non-
cancer effects should also be considered,
including such effects as hypertension, cardio-
vascular disease, diabetes, and possibly intelli-
gence quotient effects from exposure during
development. Maternal to fetal transport and
the potential actions of As during develop-
ment, especially of the nervous system, were
also considered priority areas for research.
Mechanistic studies involving biologically
plausible exposures should be performed in
conjunction with epidemiology studies.
Factors influencing inorganic As metabo-
lism in humans are largely undefined. We
should begin looking for factors, in addition
to exposure, that may correlate with adverse
effects in humans which are now attributed
primarily to As. There are several potentially
important modifying factors in As toxicity
that should be assessed. Nutritional factors
such as dietary selenium or methionine and
general nutritional status should be analyzed
for an effect on the toxic potential of As in
humans. The presence of other disease can
often modify toxic potential; for example,
liver disease may modify the toxic effects of
As. The presence ofother carcinogenic com-
pounds that may act as cocarcinogens with
As is a possibility and should be studied.
Genetic polymorphisms in As toxicity and
carcinogenesis may exist but have received
relatively little attention.
The conditions of exposure to As in
humans need to be more fully characterized,
including defining the contribution ofAs-con-
taining herbicides as well as other arsenicals.
The definition ofhow hair and nail As levels
may serve to define levels ofAs exposure, in
comparison to urine levels, could provide
additional data to define dose-effect relation-
ships. Exposures associated with As due to
cooking should be explored, including what
species of As are produced by the specific
processes andwhether As could be concentrat-
ed in foodstuffs in such cases. In addition, can
therapeutic intervention, such as with the
chelators, reduce the adverse effects of envi-
ronmental As exposure or in fact provide some
form ofpreventive treatment?
Barriers to research advancement. There
are several important barriers to the advance-
ment ofAs research. Difficulty in obtaining
funding for As research was considered a
major issue. One contributing factor seems
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to be a general lack ofinterest in As, e.g., it
does not seem to be relevant. For example,
in a review ofa grant application, one scien-
tist commented on the exotic enzymes
involved in the metabolism ofAs. A lack of
funding for programs that incorporate mul-
tidisciplinary research efforts was also con-
sidered to be an important barrier. Funding
for innovative pilot projects concerning
mechanisms in As research could prove
invaluable in defining the mechanism(s) of
this important environmental carcinogen.
Technical issues that inhibit progress
include the poor availability of radioactive
forms ofAs that are critical to many metabo-
lism studies. In addition, the lack ofa reliable
animal model for inorganic As-induced car-
cinogenesis has not been addressed. Support
for the international logistics involved in the
communication of research methodology
results and for the exchange of samples are
needed. The means for communication
among researchers and between researchers
and regulatory personnel, e.g., the EPA,
shouldbedeveloped.
Importantfuture resources. Important
current and future resources that may assist
in defining the hazards posed byAs exposure
were also discussed. Enhancement of com-
munications was an important issue and it
became clear during the meeting that it was
useful to invite participants who are, or have
been, traditionally outside the field ofAs
research. The enhanced communication
from the introduction of fresh perspectives
was evident. Other means to increase fruitful
communication could indude the develop-
ment of e-mail lists ofAs researchers. A
repository of data appearing in foreign-lan-
guage journals available in translated form
would greatly assist in international commu-
nications. Additionally, a meeting to estab-
lish conformity to As epidemiology studies
and to assist in the incorporation ofmecha-
nistic and molecular aspects into epidemio-
logystudies is acritical need.
Resources that could be developed to
assist research efforts would include several
unified protocols and methods to allowconfi-
dence when comparing data from different
sources. Such standard protocols would
indude urine analysis ofAs, induding sample
preparation; analytical methods for assess-
ment ofAs in food, water, and air; standard-
ized classification system for As-induced skin
lesions; and standardized questionnaires for
epidemiologicstudies.
Proposed unified research facilities that
would be valuable in the advancement ofAs
research included a facility for growing
human cell lines. Enhanced availability of
radioisotopic As compounds and other mate-
rials is important. The development of
knockout mice unable tO methylate inorganic
As would help in many mechanistic and
metabolism studies.
Biomarkers ofexposure and effect should
be carefully evaluated. This should include
urinary metabolites and forms ofAs in biolog-
ic fluids. Measurement ofgenetic effects, such
as dastogenic effects in lymphocytes or other
cells, should also be determined. In this
regard, studies to facilitate biomarker develop-
ment and the storage oftissue specimens from
populations with significant As exposure
should be carried out in preparation for future
studies. Although what may be the best end
point(s) for assessment is undear, certain tar-
get tissues and easilyaccessible tissues like skin
samples and lymphocytes would be valuable.
Additionally, DNA and tumor specimens
should prove invaluable in defining aberrant
gene expression induced by As and may help
in defining carcinogenic mechanisms. The use
of a central repository concept would be
appropriateforsuchstoredspecimens.
Several meetings to discuss specific aspects
ofAs toxicologywere proposed. This induded
a meeting to develop a standardized As-
induced skin lesion classification. A meeting
to determine the most appropriate biomarkers
of exposure and effects for As would also be
valuable, as would one to discuss the develop-
ment ofanimal model(s) for As-induced car-
cinogenesis. Additional information on the
effects ofAs in the human health and environ-
mental areashasbeenpublished (27-30).
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